2026 NPPES data Addiction Psychiatry Physician NPI 1487606141 MD
Verify on CMS →

ANNA FILOVA, MD

Addiction Psychiatry Physician in NEW YORK, New York. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
280
Medicare Part D claims · 19 beneficiaries · Addiction Psychiatry Physician avg: 792
Generic prescribing
94%
generic claims · 6% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$46.27
1 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

ANNA FILOVA, MD filed 280 Medicare Part D claims in 2023 as a Addiction Psychiatry Physician in NEW YORK, New York, prescribing 94% generic.

280
Part D claims, 2023
94%
generic prescribing
$46.27
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

ANNA FILOVA, MD's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

280 49th percentile higher than 49% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). This entry sits in this band. 400–600: 90,619 prescribers (7%). Above this entry. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

Board-eligible specialty (heuristic — not verified)

ANNA FILOVA, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about ANNA FILOVA, MD?

Quality data not reported

NPI registry status

Active

Issued 05/17/2006

NPI 1487606141

Primary specialty

Addiction Psychiatry Physician

Niche

667 US NPIs in this specialty

Medicare Part D claims

280 65% vs specialty avg

2023 prescription claims

Specialty avg: 792

Specialty distribution in New York

How Addiction Psychiatry Physician compares to other specialties among New York providers

New York providers

Addiction Psychiatry Physician share within New York

1. Addiction Psychiatry Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Addiction Psychiatry Physician share within New York

Specialty board-certification context

Estimated specialty board-certified rate — Addiction Psychiatry Physician (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Addiction Psychiatry Physician ABMS/AOA estimate

Est. board-certified rate (Addiction Psychiatry Physician) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Addiction Psychiatry Physician) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

ANNA FILOVA, MD appears in the CMS NPPES registry as a Addiction Psychiatry Physician provider holding MD credentials at 17 E 97TH ST APT 1C, NEW YORK, NY, 10029, with a listed phone of (646) 734-6770. NPI 1487606141 was issued on 05/17/2006. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what FILOVA most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 280 prescription claims written by this provider, covering 19 Medicare beneficiaries and totaling roughly $18K in drug spend, split 6% brand-name and 94% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Addiction Psychiatry Physician is a narrow specialty nationwide, with 667 enrolled providers across 49 states and an average of 792 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

17 E 97TH ST APT 1C
NEW YORK, NY 10029

Provider Details

NPI 1487606141
Specialty Addiction Psychiatry Physician
Credentials MD
Gender Female
NPI Issued 05/17/2006

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for ANNA FILOVA, MD. Source: openpaymentsdata.cms.gov.

Total received

$46

Largest payer

Neuronetics, Inc.

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

License & disciplinary context — New York NYSBPMC 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~100K New York medical licensees in 2023 — they are NOT specific to ANNA FILOVA, MD. To verify ANNA FILOVA, MD's current license status, search the NYSBPMC public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

312
Total board actions, New York 2023
Across 302 cases
3.12
Actions per 1,000 licensees
New York statewide rate
probation
Most common action type
89 cases

NYSBPMC publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the New York disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Generic-heavy

ANNA FILOVA, MD — brand share 6.0%
Specialty average (est.)

6% brand-name claims vs 94% generic, on 280 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

280
Total Claims
$18K
Total Drug Cost
19
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
392
Total Day Supply
11,684
Brand vs Generic
6% brand / 94% generic
Brand Drug Cost
$10K
Generic Drug Cost
$8K

Patient Demographics

Average Patient Age
71.4 years
Avg HCC Risk Score
1.64

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What ANNA FILOVA, MD prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Bupropion Xl
Bupropion Hcl
31
Trazodone Hcl
26
Lamotrigine
22
Clonazepam
20
Fluoxetine Hcl
18
Lorazepam
18
Zubsolv
Buprenorphine Hcl/Naloxone Hcl
17
Sertraline Hcl
15
Desvenlafaxine Succinate Er
Desvenlafaxine Succinate
12
Methylphenidate Er
Methylphenidate Hcl
12

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Addiction Psychiatry Physician Overview

How ANNA FILOVA, MD fits within the Addiction Psychiatry Physician landscape nationally.

667
Addiction Psychiatry Physician Providers in US
49
States with Addiction Psychiatry Physician
792
Avg Claims per Provider

ANNA FILOVA, MD's 280 claims are below the specialty average of 792.

Nearby Addiction Psychiatry Physician Providers in New York

Other clinicians with the same primary specialty enrolled in New York, drawn from the same CMS NPPES roster as FILOVA.

Compare Addiction Psychiatry Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is ANNA FILOVA, MD's specialty?
ANNA FILOVA, MD specializes in Addiction Psychiatry Physician and practices in NEW YORK, New York. Credentials: MD.
How much does ANNA FILOVA, MD prescribe under Medicare Part D?
In 2023, ANNA FILOVA, MD wrote 280 Medicare Part D claims totaling $18K in drug costs for 19 beneficiaries.
Where is ANNA FILOVA, MD located?
ANNA FILOVA, MD is located at 17 E 97TH ST APT 1C, NEW YORK, NY, 10029. Phone: (646) 734-6770.
What is ANNA FILOVA, MD's NPI number?
ANNA FILOVA, MD's National Provider Identifier (NPI) is 1487606141, issued on 05/17/2006.
Does ANNA FILOVA, MD prescribe more brand-name or generic drugs?
ANNA FILOVA, MD's prescribing is 6% brand-name and 94% generic drugs by claim count, with $10K in brand drug costs.
How many Addiction Psychiatry Physician providers are there in the US?
There are 667 Addiction Psychiatry Physician providers across 49 states in the US. The average Addiction Psychiatry Physician provider writes 792 Medicare Part D claims per year.
What drugs does ANNA FILOVA, MD prescribe most often?
Based on 2023 Medicare Part D data, ANNA FILOVA, MD's most frequently prescribed drugs include Bupropion Xl, Trazodone Hcl, Lamotrigine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does ANNA FILOVA, MD accept Medicare?
ANNA FILOVA, MD appears in CMS Medicare data with 280 Part D claims and 19 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify ANNA FILOVA, MD's credentials?
ANNA FILOVA, MD's NPI is 1487606141 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology